Kai‐Tai Chang

Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of <i>Pseudomonas aeruginosa</i>

Vincent H. Tam, Kai‐Tai Chang, Kamilia Abdelraouf et al. · Antimicrobial Agents and Chemotherapy · 2010 · 144 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Determining β-lactam exposure threshold to suppress resistance development in Gram-negative bacteria

Vincent H. Tam, Kai‐Tai Chang, Jian Zhou et al. · Journal of Antimicrobial Chemotherapy · 2017 · 113 citations · Full text

Life Sciences, Microbiology, Pharmacology +17

Uptake of Polymyxin B into Renal Cells

Kamilia Abdelraouf, Kai‐Tai Chang, Taijun Yin et al. · Antimicrobial Agents and Chemotherapy · 2014 · 62 citations · Full text

Pharmacy, Nephrology, Pharmacology +17

Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of Pseudomonas aeruginosa

Vincent H. Tam, Kai‐Tai Chang, Mark LaRocco et al. · Diagnostic Microbiology and Infectious Disease · 2007 · 46 citations

Life Sciences, Infectious Diseases, Microbiology +17

Pharmacokinetics and Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Neutropenic Murine Pneumonia Model

Jian Zhou, Kimberly R. Ledesma, Kai‐Tai Chang et al. · Antimicrobial Agents and Chemotherapy · 2017 · 40 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17